Stockholders' Equity - Schedule of Share Purchase Warrants Outstanding (Details) |
Jun. 30, 2025
$ / shares
shares
|
|---|---|
| Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | |
| Weighted Average Exercise Price (in CAD per share) | $ / shares | $ 3.81 |
| Number of warrants (in shares) | shares | 19,841,640 |
| Weighted Average Remaining Life (years) | 7 months 17 days |
| Warrant one | |
| Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | |
| Weighted Average Exercise Price (in CAD per share) | $ / shares | $ 4.05 |
| Number of warrants (in shares) | shares | 3,835,440 |
| Weighted Average Remaining Life (years) | 1 month 13 days |
| Warrant two | |
| Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | |
| Weighted Average Exercise Price (in CAD per share) | $ / shares | $ 3.75 |
| Number of warrants (in shares) | shares | 16,006,200 |
| Weighted Average Remaining Life (years) | 6 months 3 days |
| X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of warrants or rights outstanding. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|